Clinical Trial

A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 14, 2025 (before its estimated August 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study, we collected the data of immunohistochemistry, gene detection, image, OS, PFS, Orr, and so on. Secondly, the database of immunotherapy for malignant tumor was established, and the predictive model was constructed to verify and establish the rationality and validity of the biomarkers and predictive system of immunotherapy
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-05-08; most recent amendment 2025-07-11.
Status change: Not Yet Recruiting → Recruiting 2024-02-21
Trial Details
NCT Number NCT05862259
Lead Sponsor Xinqiao Hospital of Chongqing
Conditions Malignant Tumor, Immunotherapy, Artificial Intelligence
Enrollment 120 participants
Start Date 2023-08-10
Primary Completion 2025-08-10 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-14